Rise and Shine: What you need to know before the ASX opens
Link copied to
But first, here’s what you need to know right now:
March employment figures today, at 11:30am AEST.
The median forecast is for 15,000 jobs to be added, with the unemployment rate to hold at 5 per cent. Amid slowing economic growth and low inflation, the health of Australia’s jobs market is now seen as the key guide on whether the Reserve Bank of Australia will cut interest rates later this year.
No shares out of escrow today, though the following seven companies are due out of a trading halt in the next 48 hours:
Next Tuesday 23 April (public holidays, baby!):
Gold: $US1,275.91 ($1,778.49) -0.21%
Silver: $US14.99 no change
Oil (Brent): $US71.75 -0.15%
Oil (WTI): $US63.87 -0.47%
Coal: $US87.88 +0.84%
Iron ore 62% fe: $US93.44 -0.56%
Want this headstart in your inbox every morning at 8am? Go on. Subscribe here. It’s free
Vanadium prices got people talking on the Stockhead Facebook chat forum. All the chat was this story about why high vanadium prices aren’t necessarily a good thing.
These were the five most-discussed stocks on trading gossip forum HotCopper at close on Wednesday:
— HotCopper (@HotCopper) April 17, 2019
New board appointments was all it took for Neurotech (ASX:NTI) shares to rocket a phenomenal 238 per cent to a close of 3c on Wednesday.
Three new people were hired — soon after a reveal that one of its strategic advisers had lied about his qualifications.
A Chinese deal moved MGC Pharmaceuticals (ASX:MXC) shares 24 per cent to 5c at close, six-month highs.
YuShop will sell MGC Pharma’s range of Nutraceutical products.
Shares in MinRex Resources (ASX:MRR) were up 69 per cent to 2c on no news.
An interesting loser yesterday was Paradigm Biopharmaceuticals (ASX:PAR).
Shares fell 8 per cent to $1.74 at close, despite the company announcing a successful raise of $61.3 million, with more funds to follow.
Even big AFL names like Chris Judd and Leo Barry have tipped in, as per the AFR.
But analysts have raised concerns, calling into question the company’s strategy.
That’s all you need to know. Go go go!